ARTICLE | Company News
FDA extends PDUFA date for Alexza's Adasuve
January 24, 2012 1:09 AM UTC
FDA extended the PDUFA date by three months for an NDA from Alexza Pharmaceuticals Inc. (NASDAQ:ALXA) for inhaled Adasuve Staccato loxapine to treat agitation in patients with schizophrenia or bipolar...